Unity Biotechnology, Inc. — Net Income by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/128a6caf-4d15-4a18-957d-f67f395e3f96/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2024 | $-26.0M | 2024-01-01 – 2024-12-31 | evidence 0000950170-25-035564 |
| FY 2023 | $-39.9M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-044237 |
| FY 2022 | $-44.5M | 2022-01-01 – 2022-12-31 | evidence 0000950170-24-044237 |
| FY 2021 | $-60.7M | 2021-01-01 – 2021-12-31 | evidence 0001564590-22-010232 |
| FY 2020 | $-93.8M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-014854 |
| FY 2019 | $-82.2M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-010071 |
| FY 2018 | $-76.4M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-006397 |
| FY 2017 | $-44.7M | 2017-01-01 – 2017-12-31 | evidence 0001564590-19-006397 |
| FY 2016 | $-30.4M | 2016-01-01 – 2016-12-31 | evidence 0001564590-19-006397 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Unity Biotechnology, Inc. — all facts · Revenue · Operating Income